Trial of Galcanezumab in Prevention of Episodic Cluster Headache
NEJM 381:132-141, Goadsby, P.J.,et al, 2019
Intrathecal 2-hydroxypropyl-�-cyclodextrin Decreases Neurological Disease Progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial
Lancet 390:1758-1768, Ory, D.S.,et al, 2017
Safety of Pregnancy after Cerebral Venous Thrombosis
Stroke 48:3130-3133, Aguiar de Sousa, D.,et al, 2017
Safety of Pregnancy After Cerebral Venous Thrombosis
Stroke 47:713-718, Aguiar de Sousa, D.,et al, 2016
When it is Safe to Return to Driving Following First-Ever Seizure?
JNNP 86:60-64, Brown, J.W.L.,et al, 2015
Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease
Neurol 76:1372-1376, Sone, J.,et al, 2011
Intravenous Dihydroergotamine for Inpatient Management of Refractory Primary Headaches
Neurol 77:1827-1832, Nagy, A.J.,et al, 2011
Durability of Endovascular Therapy for Symptomatic Intracranial Atherosclerosis
Stroke 39:1766-1769, Mazighi,M.,et al, 2008
Treatment of Medically Intractable Cluster Headache by Occipital Nerve Stimulation: Long-Term Follow-Up of Eight Patients
Lancet 369:1099-1065, Burns,B.,et al, 2007
Zolmitriptan Nasal Spray in the Acute Treatment of Cluster Headache: A Double-Blind Study
Neurol 69:821-826, Rapoport,A.M.,et al, 2007